Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.
作者信息
Mazzone Theodore
机构信息
Department of Medicine, University of Illinois at Chicago, 60612, USA.
出版信息
Circulation. 2010 Nov 23;122(21):2201-11. doi: 10.1161/CIRCULATIONAHA.109.913350.
Abstract
摘要
相似文献
1
Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.糖尿病患者强化降糖与心血管疾病预防：整合近期临床试验数据
Circulation. 2010 Nov 23;122(21):2201-11. doi: 10.1161/CIRCULATIONAHA.109.913350.
2
Intensive glucose lowering treatment in type 2 diabetes.2型糖尿病的强化降糖治疗
BMJ. 2011 Jul 26;343:d4243. doi: 10.1136/bmj.d4243.
3
Glycemic control and cardiovascular disease: what's a doctor to do?血糖控制与心血管疾病：医生该如何应对？
Curr Diab Rep. 2012 Jun;12(3):255-64. doi: 10.1007/s11892-012-0268-5.
4
5
[Is an intensive glycaemic control beneficial in diabetes type 2?].强化血糖控制对2型糖尿病有益吗？
Dtsch Med Wochenschr. 2011 Sep;136(39):1940. doi: 10.1055/s-0031-1286394. Epub 2011 Sep 22.
6
[Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].[糖尿病患者的血压控制。关注餐后血糖值与心血管风险]
MMW Fortschr Med. 2012 Feb 23;154(3):82-3.
7
Metformin and risk of cardiovascular disease.二甲双胍与心血管疾病风险
Cardiology. 1999;91(3):203-4. doi: 10.1159/000006910.
8
Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.通过控制 2 型糖尿病患者的血糖水平来预防心血管疾病：一项随机临床试验的荟萃分析。
Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):604-12. doi: 10.1016/j.numecd.2009.03.021. Epub 2009 May 8.
9
The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.强化血糖控制与 2 型糖尿病血管并发症的关系：一项荟萃分析。
Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):596-603. doi: 10.1016/j.numecd.2009.07.004. Epub 2009 Oct 9.
10
Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.非胰岛素依赖型和胰岛素依赖型糖尿病患者外源性胰岛素给药与心血管风险
Ann Intern Med. 1996 Jan 1;124(1 Pt 2):104-9. doi: 10.7326/0003-4819-124-1_part_2-199601011-00005.
引用本文的文献
1
Adipocyte-derived small extracellular vesicles exacerbate diabetic ischemic heart injury by promoting oxidative stress and mitochondrial-mediated cardiomyocyte apoptosis.脂肪细胞衍生的小细胞外囊泡通过促进氧化应激和线粒体介导的心肌细胞凋亡加重糖尿病缺血性心脏损伤。
Redox Biol. 2025 Feb;79:103443. doi: 10.1016/j.redox.2024.103443. Epub 2024 Dec 9.
2
Assessing mortality risk in Type 2 Diabetes patients with prolonged ASCVD risk factors: the inclusive Poh-Ai predictive scoring system with CAC Score integration.评估伴有长期动脉粥样硬化性心血管疾病（ASCVD）危险因素的2型糖尿病患者的死亡风险：纳入冠状动脉钙化（CAC）评分的包容性博爱预测评分系统。
Diabetol Metab Syndr. 2024 May 19;16(1):104. doi: 10.1186/s13098-024-01341-9.
3
Impact of preoperative type 2 diabetes mellitus on the outcomes of patients with gastric cancer following gastrectomy: Analysis of 834 patients using propensity score matching.术前2型糖尿病对胃癌患者胃切除术后结局的影响：采用倾向评分匹配法对834例患者的分析
Biomed Rep. 2023 Oct 19;19(6):97. doi: 10.3892/br.2023.1679. eCollection 2023 Dec.
4
Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia/reperfusion injury with diabetes.基于网络药理学的舒心汤对糖尿病心肌缺血/再灌注损伤的保护作用及潜在机制研究
World J Diabetes. 2023 Jul 15;14(7):1057-1076. doi: 10.4239/wjd.v14.i7.1057.
5
Therapeutic Potential of Linn. in Attenuating Cardiovascular Risk Factors.Linn. 在减轻心血管危险因素方面的治疗潜力。
Pharmaceuticals (Basel). 2023 May 29;16(6):807. doi: 10.3390/ph16060807.
6
Resveratrol Inhibits High Glucose-Induced H9c2 Cardiomyocyte Hypertrophy and Damage via RAGE-Dependent Inhibition of the NF-B and TGF-1/Smad3 Pathways.白藜芦醇通过依赖晚期糖基化终末产物受体（RAGE）抑制核因子κB（NF-κB）和转化生长因子β1（TGF-β1）/Smad3信号通路，从而抑制高糖诱导的H9c2心肌细胞肥大和损伤。
Evid Based Complement Alternat Med. 2022 Feb 25;2022:7781910. doi: 10.1155/2022/7781910. eCollection 2022.
7
Post-exercise Warm or Cold Water Immersion to Augment the Cardiometabolic Benefits of Exercise Training: A Proof of Concept Trial.运动后温水或冷水浸泡以增强运动训练的心脏代谢益处：一项概念验证试验
Front Physiol. 2021 Nov 3;12:759240. doi: 10.3389/fphys.2021.759240. eCollection 2021.
8
Prognostic value of preoperative body mass index for diabetic patients with non-metastasis gastric cancer: a single center experience.术前体重指数对非转移性糖尿病胃癌患者的预后价值：单中心经验。
BMC Surg. 2021 Aug 9;21(1):320. doi: 10.1186/s12893-021-01316-x.
9
Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice.小型细胞外微小囊泡介导功能障碍的脂肪细胞和心肌细胞之间的病理性通讯，作为一种加剧糖尿病小鼠缺血/再灌注损伤的新机制。
Circulation. 2020 Mar 24;141(12):968-983. doi: 10.1161/CIRCULATIONAHA.119.042640. Epub 2020 Jan 10.
10
Plin5/p-Plin5 Guards Diabetic CMECs by Regulating FFAs Metabolism Bidirectionally.Plin5/p-Plin5 通过双向调节 FFAs 代谢来保护糖尿病 CMECs。
Oxid Med Cell Longev. 2019 Oct 17;2019:8690746. doi: 10.1155/2019/8690746. eCollection 2019.
本文引用的文献
1
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.2 型糖尿病患者症状性、严重低血糖与死亡的相关性：ACCORD 研究的回顾性流行病学分析。
BMJ. 2010 Jan 8;340:b4909. doi: 10.1136/bmj.b4909.
2
Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study.合并症影响糖尿病患者血糖控制与心血管结局的关系：一项队列研究。
Ann Intern Med. 2009 Dec 15;151(12):854-60. doi: 10.7326/0003-4819-151-12-200912150-00005.
3
Projecting the future diabetes population size and related costs for the U.S.预测美国未来的糖尿病患病人数及相关费用
Diabetes Care. 2009 Dec;32(12):2225-9. doi: 10.2337/dc09-0459.
4
Human C-reactive protein does not promote atherosclerosis in transgenic rabbits.人C反应蛋白不会在转基因兔中促进动脉粥样硬化。
Circulation. 2009 Nov 24;120(21):2088-94. doi: 10.1161/CIRCULATIONAHA.109.872796. Epub 2009 Nov 9.
5
C-reactive protein and coronary disease: is there a causal link?C反应蛋白与冠心病：存在因果联系吗？
Circulation. 2009 Nov 24;120(21):2036-9. doi: 10.1161/CIRCULATIONAHA.109.907212. Epub 2009 Nov 9.
6
C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.C反应蛋白作为冠心病的一个危险因素：美国预防服务工作组的系统评价和荟萃分析
Ann Intern Med. 2009 Oct 6;151(7):483-95. doi: 10.7326/0003-4819-151-7-200910060-00009.
7
Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.阿司匹林用于心血管事件的一级预防：比较伴或不伴糖尿病患者的系统评价和荟萃分析。
Diabetes Care. 2009 Dec;32(12):2300-6. doi: 10.2337/dc09-1297. Epub 2009 Sep 9.
8
Intensive glucose control and macrovascular outcomes in type 2 diabetes.强化血糖控制与 2 型糖尿病的大血管结局。
Diabetologia. 2009 Nov;52(11):2288-98. doi: 10.1007/s00125-009-1470-0. Epub 2009 Aug 5.
9
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.强化降糖治疗可降低有钙化性冠状动脉粥样硬化的退伍军人事务糖尿病试验参与者的心血管疾病事件。
Diabetes. 2009 Nov;58(11):2642-8. doi: 10.2337/db09-0618. Epub 2009 Aug 3.
10
Systematic review: glucose control and cardiovascular disease in type 2 diabetes.系统评价：2型糖尿病患者的血糖控制与心血管疾病
Ann Intern Med. 2009 Sep 15;151(6):394-403. doi: 10.7326/0003-4819-151-6-200909150-00137. Epub 2009 Jul 20.
Zotero 插件